Report Detail
Global and United States Human Injection Flu Vaccine Market Report & Forecast 2022-2028
- RnM4421314 |
- 09 April, 2022 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Market Analysis and Insights: Global and United States Human Injection Flu Vaccine Market
This report focuses on global and United States Human Injection Flu Vaccine market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Human Injection Flu Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Trivalent Influenza Vaccine accounting for % of the Human Injection Flu Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, 6 Months to 3 Years was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Human Injection Flu Vaccine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Human Injection Flu Vaccine Scope and Market Size
Human Injection Flu Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Injection Flu Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Human Injection Flu Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Human Injection Flu Vaccine market is segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application, the Human Injection Flu Vaccine market is segmented into
6 Months to 3 Years
> 3 Years
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Human Injection Flu Vaccine Market Share Analysis
Human Injection Flu Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Injection Flu Vaccine business, the date to enter into the Human Injection Flu Vaccine market, Human Injection Flu Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Table of Contents
1 Study Coverage
- 1.1 Human Injection Flu Vaccine Product Introduction
- 1.2 Global Human Injection Flu Vaccine Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Human Injection Flu Vaccine Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Human Injection Flu Vaccine Sales in Volume for the Year 2017-2028
- 1.3 United States Human Injection Flu Vaccine Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Human Injection Flu Vaccine Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Human Injection Flu Vaccine Sales in Volume for the Year 2017-2028
- 1.4 Human Injection Flu Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Human Injection Flu Vaccine in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Human Injection Flu Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Human Injection Flu Vaccine Market Dynamics
- 1.5.1 Human Injection Flu Vaccine Industry Trends
- 1.5.2 Human Injection Flu Vaccine Market Drivers
- 1.5.3 Human Injection Flu Vaccine Market Challenges
- 1.5.4 Human Injection Flu Vaccine Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Human Injection Flu Vaccine Market Segment by Type
- 2.1.1 Trivalent Influenza Vaccine
- 2.1.2 Quadrivalent Influenza Vaccine
- 2.2 Global Human Injection Flu Vaccine Market Size by Type
- 2.2.1 Global Human Injection Flu Vaccine Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Human Injection Flu Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Human Injection Flu Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Human Injection Flu Vaccine Market Size by Type
- 2.3.1 United States Human Injection Flu Vaccine Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Human Injection Flu Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Human Injection Flu Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Human Injection Flu Vaccine Market Segment by Application
- 3.1.1 6 Months to 3 Years
- 3.1.2 > 3 Years
- 3.2 Global Human Injection Flu Vaccine Market Size by Application
- 3.2.1 Global Human Injection Flu Vaccine Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Human Injection Flu Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Human Injection Flu Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Human Injection Flu Vaccine Market Size by Application
- 3.3.1 United States Human Injection Flu Vaccine Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Human Injection Flu Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Human Injection Flu Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Injection Flu Vaccine Competitor Landscape by Company
- 4.1 Global Human Injection Flu Vaccine Market Size by Company
- 4.1.1 Top Global Human Injection Flu Vaccine Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Human Injection Flu Vaccine Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Human Injection Flu Vaccine Sales by Manufacturer (2017-2022)
- 4.1.4 Global Human Injection Flu Vaccine Price by Manufacturer (2017-2022)
- 4.2 Global Human Injection Flu Vaccine Concentration Ratio (CR)
- 4.2.1 Human Injection Flu Vaccine Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Injection Flu Vaccine in 2021
- 4.2.3 Global Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Human Injection Flu Vaccine Manufacturing Base Distribution, Product Type
- 4.3.1 Global Human Injection Flu Vaccine Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Human Injection Flu Vaccine Product Type
- 4.3.3 Date of International Manufacturers Enter into Human Injection Flu Vaccine Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Human Injection Flu Vaccine Market Size by Company
- 4.5.1 Top Human Injection Flu Vaccine Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Human Injection Flu Vaccine Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Human Injection Flu Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Human Injection Flu Vaccine Market Size by Region
- 5.1 Global Human Injection Flu Vaccine Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Human Injection Flu Vaccine Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Human Injection Flu Vaccine Sales in Volume by Region: 2017-2022
- 5.2.2 Global Human Injection Flu Vaccine Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Human Injection Flu Vaccine Market Size in Value by Region (2017-2028)
- 5.3.1 Global Human Injection Flu Vaccine Sales in Value by Region: 2017-2022
- 5.3.2 Global Human Injection Flu Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Human Injection Flu Vaccine Market Size YoY Growth 2017-2028
- 6.1.2 North America Human Injection Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Human Injection Flu Vaccine Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Human Injection Flu Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Human Injection Flu Vaccine Market Size YoY Growth 2017-2028
- 6.3.2 Europe Human Injection Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Human Injection Flu Vaccine Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Human Injection Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Human Injection Flu Vaccine Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Human Injection Flu Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Sanofi
- 7.1.1 Sanofi Corporation Information
- 7.1.2 Sanofi Description and Business Overview
- 7.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Sanofi Human Injection Flu Vaccine Products Offered
- 7.1.5 Sanofi Recent Development
- 7.2 CSL
- 7.2.1 CSL Corporation Information
- 7.2.2 CSL Description and Business Overview
- 7.2.3 CSL Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 CSL Human Injection Flu Vaccine Products Offered
- 7.2.5 CSL Recent Development
- 7.3 GSK
- 7.3.1 GSK Corporation Information
- 7.3.2 GSK Description and Business Overview
- 7.3.3 GSK Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 GSK Human Injection Flu Vaccine Products Offered
- 7.3.5 GSK Recent Development
- 7.4 Viatris
- 7.4.1 Viatris Corporation Information
- 7.4.2 Viatris Description and Business Overview
- 7.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 Viatris Human Injection Flu Vaccine Products Offered
- 7.4.5 Viatris Recent Development
- 7.5 AstraZeneca
- 7.5.1 AstraZeneca Corporation Information
- 7.5.2 AstraZeneca Description and Business Overview
- 7.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 AstraZeneca Human Injection Flu Vaccine Products Offered
- 7.5.5 AstraZeneca Recent Development
- 7.6 Hualan Bio
- 7.6.1 Hualan Bio Corporation Information
- 7.6.2 Hualan Bio Description and Business Overview
- 7.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.6.4 Hualan Bio Human Injection Flu Vaccine Products Offered
- 7.6.5 Hualan Bio Recent Development
- 7.7 Changchun Institute of Biological
- 7.7.1 Changchun Institute of Biological Corporation Information
- 7.7.2 Changchun Institute of Biological Description and Business Overview
- 7.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Products Offered
- 7.7.5 Changchun Institute of Biological Recent Development
- 7.8 Sinovac
- 7.8.1 Sinovac Corporation Information
- 7.8.2 Sinovac Description and Business Overview
- 7.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.8.4 Sinovac Human Injection Flu Vaccine Products Offered
- 7.8.5 Sinovac Recent Development
- 7.9 Jiangsu GDK
- 7.9.1 Jiangsu GDK Corporation Information
- 7.9.2 Jiangsu GDK Description and Business Overview
- 7.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.9.4 Jiangsu GDK Human Injection Flu Vaccine Products Offered
- 7.9.5 Jiangsu GDK Recent Development
- 7.10 KM Biologics
- 7.10.1 KM Biologics Corporation Information
- 7.10.2 KM Biologics Description and Business Overview
- 7.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue and Gross Margin (2017-2022)
- 7.10.4 KM Biologics Human Injection Flu Vaccine Products Offered
- 7.10.5 KM Biologics Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Human Injection Flu Vaccine Industry Chain Analysis
- 8.2 Human Injection Flu Vaccine Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Human Injection Flu Vaccine Distributors
- 8.3 Human Injection Flu Vaccine Production Mode & Process
- 8.4 Human Injection Flu Vaccine Sales and Marketing
- 8.4.1 Human Injection Flu Vaccine Sales Channels
- 8.4.2 Human Injection Flu Vaccine Distributors
- 8.5 Human Injection Flu Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Human Injection Flu Vaccine. Industry analysis & Market Report on Human Injection Flu Vaccine is a syndicated market report, published as Global and United States Human Injection Flu Vaccine Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Human Injection Flu Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
